IIT Kanpur licenses gene therapy for treating hereditary eye diseases to Reliance Life Sciences
New Delhi: The Indian Institute of Technology (IIT) Kanpur has licensed a pioneering technology to Reliance Life Sciences Pvt Ltd ...
Read moreDetailsNew Delhi: The Indian Institute of Technology (IIT) Kanpur has licensed a pioneering technology to Reliance Life Sciences Pvt Ltd ...
Read moreDetailsNew Delhi: Reliance Life Sciences has developed an RT-PCR kit that promises diagnosis of COVID-19 infection in about 2 hours, ...
Read moreDetails
Tensions between the US and Venezuela have reached a seemingly critical level over what the US administration ostensibly calls its...
Read moreDetailsDespite the newfound bonhomie between China and India in the wake of US President Donald Trump’s tariff war, China is...
Read moreDetailsIn its latest annual review, the International Monetary Fund (IMF) has assigned a ‘C’ grade to India’s national accounts statistics...
Read moreDetailsLast month, along with Pakistan and Iraq, India was elected to the UN Human Rights Council from Asia. The UNHRC...
Read moreDetails
